{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Rezolute, Inc.
Is Rezolute, Inc. technically bullish or bearish?
As of June 11, 2025, Rezolute, Inc. shows a mildly bullish trend based on weekly indicators like the MACD and Bollinger Bands, despite some caution from bearish signals in the monthly timeframe and daily moving averages.
What does Rezolute, Inc. do?
Rezolute, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology sector, currently reporting a net profit loss of $19 million and a market cap of $353.19 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -87.28%.
How big is Rezolute, Inc.?
As of Jun 24, Rezolute, Inc. has a market capitalization of 353.19 million, with net sales of 0.00 million and a net profit of -73.00 million over the last four quarters. The company has shareholder's funds of 121.00 million and total assets of 132.74 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
